Mosaic Biosciences is advancing a fundamentally new class of synthetic materials to support native tissue regeneration. With its proprietary platform technology, Mosaic expects to significantly impact the field of tissue regeneration.

from http://www.mosaicbio.com/

Patents 15show all

  • 6
    A61K - Preparations for medical, dental, or toilet purposes
  • 4
    A61L - Methods or apparatus for sterilising materials or objects in general
  • 4
    C08L - Compositions of macromolecular compounds
  • 2
    C07K - Peptides
  • 2
    C12N - Microorganisms or enzymes
  • 2
    C12Y - Enzymes

SEC Filings show all


2
D

Contact Information

Boulder, CO
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$3,274,00011-502014-02-10Operating

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2014-02-10$2,274,000Series Unknown
2011-11-08$1,000,000Series AHigh Country Venture, Morgenthaler Ventures, HealthCare Ventures

Key Executives

  • Martin Stanton
    Executive Officer, Director
  • Nassim Usman
    Director
  • Augustine Lawlor
    Director
  • Mark Lupa
    Director
  • Guy Katsav
    Director